Bio-Techne (TECH) Short term Debt (2016 - 2023)
Bio-Techne (TECH) recorded quarterly Short term Debt of $1.8 million in Q3 2023, down 50.0% quarter-over-quarter from $3.5 million in Q2 2023, and down 76.35% on a YoY basis from $7.4 million in Q3 2022.
Bio-Techne (TECH) Short term Debt (2016 - 2023) Analysis & Trends
Bio-Techne's Short term Debt history runs 8 years deep, the most recent figure standing at $1.8 million for Q3 2023.
- In Q3 2023, Short term Debt fell 76.35% year-over-year to $1.8 million; the TTM figure through Sep 2023 stood at $1.8 million (down 76.35% YoY), while the FY2023 annual figure was $3.5 million, down 72.0% from the prior year.
- Short term Debt was $1.8 million for Q3 2023 at Bio-Techne, down from $3.5 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $12.5 million in Q1 2019 to a low of $1.8 million in Q3 2023.
- Historically, Short term Debt has averaged $8.2 million across 5 years, with a median of $6.8 million in 2020.
- The sharpest annual moves came in 2019 and 2023: Short term Debt soared 257.14% in 2019, then plunged 76.35% in 2023.
- A 5-year view of Short term Debt shows it stood at $12.5 million in 2019, then slumped by 60.14% to $5.0 million in 2020, then plunged by 59.86% to $2.0 million in 2021, then soared by 270.0% to $7.4 million in 2022, then slumped by 76.35% to $1.8 million in 2023.
- The last three Short term Debt figures came in at $1.8 million (Q3 2023), $3.5 million (Q2 2023), and $5.2 million (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 1.75 Mn |
| Jun 30, 2023 | 3.50 Mn |
| Mar 31, 2023 | 5.25 Mn |
| Sep 30, 2022 | 7.40 Mn |
| Jun 30, 2022 | 12.50 Mn |
| Mar 31, 2022 | 12.50 Mn |
| Dec 31, 2021 | 2.00 Mn |
| Sep 30, 2021 | 5.00 Mn |
| Jun 30, 2021 | 12.50 Mn |
| Mar 31, 2021 | 5.07 Mn |
| Dec 31, 2020 | 4.98 Mn |
| Sep 30, 2020 | 5.79 Mn |
| Jun 30, 2020 | 12.50 Mn |
| Mar 31, 2020 | 6.15 Mn |
| Dec 31, 2019 | 12.50 Mn |
| Sep 30, 2019 | 12.50 Mn |
| Jun 30, 2019 | 12.50 Mn |
| Mar 31, 2019 | 12.50 Mn |
| Dec 31, 2018 | 12.50 Mn |
| Sep 30, 2018 | 12.50 Mn |